Chemomab Therapeutics Stock (NASDAQ: CMMB) stock price, news, charts, stock research, profile.
Open | $2.26 |
Close | $1.90 |
Volume / Avg. | 560.44K / 208.89K |
Day Range | $1.82 - $2.27 |
52 Wk Range | 0.42 - 2.55 |
Market Cap | $27.73M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 0.14% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Chemomab Therapeutics (NASDAQ:CMMB) through any online brokerage.
Other companies in Chemomab Therapeutics’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS), Immuneering (NASDAQ:IMRX), Lumos Pharma (NASDAQ:LUMO) and Aligos Therapeutics (NASDAQ:ALGS).
Chemomab Therapeutics has a consensus price target of $11.75.
The stock price for Chemomab Therapeutics (NASDAQ: CMMB) is $1.95 last updated September 6, 2024 at 7:30 PM EDT.
There are no upcoming dividends for Chemomab Therapeutics.
Chemomab Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Chemomab Therapeutics.
Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.